Monokine gene expression in normal human liver: selective involvement of the portal compartment.

Monokines play a major role in the regulation of hepatocyte functions. To document a possible in situ production of these mediators under physiological conditions, expression of IL-1 beta and of IL-6 genes was analyzed by in situ hybridization in four histologically normal human livers. We detected cells containing IL-1 beta mRNA or IL-6 mRNA in all cases. Cells expressing either the IL-1 beta gene or the IL-6 gene were found with equal frequency and were similarly distributed. Although present in all liver compartments, they were selectively enriched in portal areas, in which they were detected both in endothelial positions and in perivascular connective tissues. Few positive cells were observed in hepatic lobules, most of them being located in the walls of centrolobular veins, in an endothelial position. Subcapsular cells were also shown to express monokine genes. The location of positive cells and their pattern of labelling suggested that macrophages, fibroblasts and endothelial cells were the main cell populations expressing monokine genes. In contrast, Kupffer cells, biliary epithelial cells and hepatocytes did not express monokine genes. No marker of immune activation other than monokine gene expression was detected in these histologically normal livers. The expression of the IL-1 beta gene and of the IL-6 gene may be induced by gut-derived LPS, and could play a role in the modulation of hepatocyte function in normal liver.

[1]  J. Trapani,et al.  Activation of cytotoxic cells in hyperplastic lymph nodes from HIV-infected patients. , 1991, AIDS.

[2]  M. Peuchmaur,et al.  In situ production of interleukins in hyperplastic thymus from myasthenia gravis patients. , 1991, Human pathology.

[3]  N. Brousse,et al.  Production of interleukins in human immunodeficiency virus-1-replicating lymph nodes. , 1990, The Journal of clinical investigation.

[4]  J. Gauldie,et al.  IL-6 functions as an exocrine hormone in inflammation. Hepatocytes undergoing acute phase responses require exogenous IL-6. , 1990, Journal of immunology.

[5]  D. Hazuda,et al.  Processing of precursor interleukin 1 beta and inflammatory disease. , 1990, The Journal of biological chemistry.

[6]  P. Heinrich,et al.  Fate of interleukin-6 in the rat. Involvement of skin in its catabolism. , 1990, European journal of biochemistry.

[7]  M. Röllinghoff,et al.  IL-1 beta is secreted by activated murine macrophages as biologically inactive precursor. , 1990, Journal of immunology.

[8]  M. Peuchmaur,et al.  IL-2 mRNA expression in Tac-positive malignant lymphomas. , 1990, The American journal of pathology.

[9]  M. T. Brewer,et al.  Primary structure and functional expression from complementary DNA of a human interleukin-1 receptor antagonist , 1990, Nature.

[10]  Robert C. Thompson,et al.  Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor , 1990, Nature.

[11]  G. Ciliberto,et al.  Dual control of C‐reactive protein gene expression by interleukin‐1 and interleukin‐6. , 1989, The EMBO journal.

[12]  L. Vanhaelst,et al.  Localization of interleukin 6 mRNA in human tonsils by in situ hybridization , 1989, European journal of immunology.

[13]  R. Cortese,et al.  Interleukin 6 induces a liver-specific nuclear protein that binds to the promoter of acute-phase genes. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[14]  T. Komori,et al.  Pathogenic significance of interleukin-6 (IL-6/BSF-2) in Castleman's disease , 1989 .

[15]  P. Heinrich,et al.  Fate and biological action of human recombinant interleukin 1β in the rat in vivo , 1989, European journal of immunology.

[16]  T. Kishimoto,et al.  The biology of interleukin-6. , 1989, Blood.

[17]  R. Cortese,et al.  The human haptoglobin gene promoter: interleukin‐6‐responsive elements interact with a DNA‐binding protein induced by interleukin‐6. , 1989, The EMBO journal.

[18]  L. Moldawer,et al.  Endotoxemia elicits increased circulating beta 2-IFN/IL-6 in man. , 1989, Journal of immunology.

[19]  T. Hirano,et al.  Bacterial lipopolysaccharide and inflammatory mediators augment IL-6 secretion by human endothelial cells. , 1989, Journal of immunology.

[20]  W. Fiers,et al.  Genes for IFN-beta-2 (IL-6), tumor necrosis factor, and IL-1 are expressed at high levels in the organs of normal individuals. , 1988, Journal of immunology.

[21]  G. Ramadori,et al.  Interleukin 6, the third mediator of acute‐phase reaction, modulates hepatic protein synthesis in human and mouse. Comparison with interleukin 1 β and tumor necrosis factor‐α , 1988 .

[22]  F. Houssiau,et al.  Interleukin-6 in synovial fluid and serum of patients with rheumatoid arthritis and other inflammatory arthritides. , 1988, Arthritis and rheumatism.

[23]  W. M. Weaver,et al.  Regulation of tumor necrosis factor/cachectin and IL-1 secretion in human mononuclear phagocytes. , 1988, Journal of immunology.

[24]  T. Hirano,et al.  Action of recombinant human interleukin 6, interleukin 1β and tumor necrosis factor α on the mRNA induction of acute‐phase proteins , 1988 .

[25]  T. Hirano,et al.  Induction of rat acute‐phase proteins by interleukin 6 in vivo , 1988, European journal of immunology.

[26]  A. C. Webb,et al.  Human pro-IL-1 beta gene expression in monocytic cells is regulated by two distinct pathways. , 1988, Journal of immunology.

[27]  J. Emond,et al.  LIVER TRANSPLANTATION WITH REDUCED‐SIZE DONOR ORGANS , 1988, Transplantation.

[28]  J. Gauldie,et al.  Interaction among hepatocyte-stimulating factors, interleukin 1, and glucocorticoids for regulation of acute phase plasma proteins in human hepatoma (HepG2) cells. , 1987, Journal of immunology.

[29]  P. Sehgal,et al.  Bacterial lipopolysaccharide (endotoxin) enhances expression and secretion of beta 2 interferon by human fibroblasts , 1987, The Journal of experimental medicine.

[30]  C. Hack,et al.  SERUM LEVELS OF INTERLEUKIN-6 AND ACUTE PHASE RESPONSES , 1987, The Lancet.

[31]  M. Lefranc,et al.  A gamma 3 hinge region probe: first specific human immunoglobulin subclass probe , 1986, FEBS letters.

[32]  C. Milstein,et al.  Human immunoglobulin heavy chain genes: evolutionary comparisons of C mu, C delta and C gamma genes and associated switch sequences. , 1981, Nucleic acids research.

[33]  D. Mason,et al.  The labeled antigen method of immunoenzymatic staining. , 1979, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[34]  H. Thomas,et al.  Role of the liver in controlling the immunogenicity of commensal bacteria in the gut. , 1973, Lancet.

[35]  B. Beutler,et al.  The essential role of the UA-rich sequence in endotoxin-induced cachectin/TNF synthesis. , 1990, European cytokine network.

[36]  C. Dinarello Interleukin-1 and its biologically related cytokines. , 1989, Advances in immunology.